Back to Search
KENNETH BEER, MD
MD
Dermatology Physician
NPI: 1699764993IndividualAccepts Medicare
Specialties, Licenses & Credentials
MOHS-Micrographic Surgery Physician
Dermatology — MOHS-Micrographic Surgery
Code: 207ND0101X
ME59480(FL)
Dermatopathology Physician
Dermatology — Dermatopathology
Code: 207ND0900X
ME59480(FL)
Procedural Dermatology Physician
Dermatology — Procedural Dermatology
Code: 207NS0135X
ME59480(FL)
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
ME59480(FL)
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1989
Clinical Trials (4)
4
Linked Trials
0
Recruiting
0
With Results
Kybella for the Treatment of Flank Fat (FF)
NCT04841551COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Upper Facial Remodeling With Perlane-L and Dysport
NCT01354743COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Brow Lifting With Dysport
NCT01401803COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Latisse (Bimatoprost .03% Opthalmic Solution) for the Treatment of Hypotrichosis of the Eyebrows: Latisse Versus Placebo
NCT01387906COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
The Impact of Submental Deoxycholic Acid Injections on Neck Surgery
PMID 31860219·J Drugs Dermatol·2019
8-other
Bimatoprost 0.03% solution (latisse) for eyelash enhancement.
PMID 19478690·Med Lett Drugs Ther·2009
8-other
Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
PMID 15871316·Dermatol Surg·2005
3-trial
Botulinum A toxin (BOTOX) in the lower eyelid: dose-finding study.
PMID 12930337·Dermatol Surg·2003
8-other
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
PMID 12063480·J Am Acad Dermatol·2002
3-trial
Clinicopathologic correlation of delayed-onset periorbital poly-L-lactic acid nodules.
PMID 19207333·Dermatol Surg·2009
5-case
Disfiguring scarring following mesotherapy-associated Mycobacterium cosmeticum infection.
PMID 19363858·J Drugs Dermatol·2009
5-case
Evaluation of injectable CaHA for the treatment of mid-face volume loss.
PMID 18459517·J Drugs Dermatol·2008
8-other
Sequelae from inadvertent long-term use of potent topical steroids.
PMID 17679193·J Drugs Dermatol·2007
5-case
A single-center, open-label study on the use of injectable poly-L-lactic acid for the treatment of moderate to severe scarring from acne or varicella.
PMID 18086054·Dermatol Surg·2007
8-other
A randomized, evaluator-blinded comparison of efficacy of hyaluronic acid gel and avian-sourced hylan B plus gel for correction of nasolabial folds.
PMID 17661935·Dermatol Surg·2007
4-observational
Nasal reconstruction using 20 mg/ml cross-linked hyaluronic acid.
PMID 16703786·J Drugs Dermatol·2006
5-case
Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
PMID 16442037·Dermatol Surg·2006
4-observational
Delayed complications from thread-lifting: report of a case, discussion of treatment options, and consideration of implications for future technology.
PMID 18462429·Dermatol Surg·2008
5-case
Recurrent basal cell carcinoma discovered using positron emission tomography (PET) scanning.
PMID 19112803·J Drugs Dermatol·2008
5-case
MET Y1253D-activating point mutation and development of distant metastasis in advanced head and neck cancers.
PMID 19639388·Clin Exp Metastasis·2009
8-other
Ablative fractional laser resurfacing for the treatment of a third-degree burn.
PMID 19271380·J Drugs Dermatol·2009
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 N DIXIE HWY, SUITE 305
WEST PALM BEACH, FL 33401 - Phone
- (561) 600-4848
Quick Facts
- NPI
- 1699764993
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 37
- Clinical Trials
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile